Targeting genes like p53 upregulated modulator of apoptosis (PUMA), cyclin E1, and K(lysine) acetyltransferase 5 (KAT5) in mouse models of acute liver injury, chronic liver fibrosis, and HCC, exosome RNPs exhibited significant therapeutic potential. Here, KAT5 is linked to hepatocellular carcinoma.